longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BAYZED HEALTH

02609

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 117.74, above the reasonable range, cheaper than 1.15% of the time in the past 1 years, and the industry ranks 17/21, the industry Median 9.74.

117.74xP/E
HK$2.99Stock price
HK$0.03Earnings per share
117.74xP/E
Stock priceHK$2.99Earnings per shareHK$0.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-269.29x
Typical range
-453.11x–-143.74x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 9.74x
0306090120

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 9.74x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
02609HKBAYZED HEALTH
117.74x--HK$3.94B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.